N

North Carolina Clinical Research | Raleigh, NC

Research site

(Unclaimed)

Location

2615 Lake Drive, Suite 301, Raleigh, North Carolina, United States of America

Site insights

Top conditions

Top treatments

azelastine hydrochloride

fluticasone propionate

SUN-101

Fluticasone Propionate

Olodaterol

RN316

PF-04950615

Ciclesonide

azelastine Hcl

HFA

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 62 total trials

A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it)

This study is to evaluate the Pharmacodynamic (PD), safety, tolerability, Pharmacokinetic (PK), and plasma biomarker response of KAN-101 in participa...

Active, not recruiting

Celiac Disease

Drug: Cohort 2 in Part A

Drug: Group 4 in Part B and Part C

Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients

This study is to characterize the safety and tolerability of an investigational drug called DONQ52 and consists of a single ascending dose part (Part...

Active, not recruiting

Celiac Disease

Drug: Placebo

Drug: DONQ52

VTP-1000 in Adults With Celiac Disease

GLU001 is a first-in-human clinical trial to assess the safety and tolerability of VTP-1000 for adults with celiac disease. This trial will assess VT...

Enrolling

Celiac Disease

Other: Matched Placebo

Biological: VTP-1000